RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
IDEXX Laboratories Stock

IDEXX Laboratories ROE 2025

IDEXX Laboratories ROE

0.56

Ticker

IDXX

ISIN

US45168D1046

WKN

888210

In 2025, IDEXX Laboratories's return on equity (ROE) was 0.56, a -2.23% increase from the 0.57 ROE in the previous year.

IDEXX Laboratories Aktienanalyse

What does IDEXX Laboratories do?

The history of IDEXX Laboratories Inc began in 1983 when a research team from the University of Maine developed technology for the automatic analysis of animal blood. The first products were soon sold and the company grew rapidly. Today, IDEXX is a leading global provider of veterinary diagnostic and IT solutions, recognized by customers in over 175 countries. IDEXX's business model is based on innovation and a comprehensive understanding of the needs of veterinarians and their patients. The company offers a wide range of products and solutions that make the diagnosis and treatment of animal diseases easier and more reliable. These include tests and devices for blood analysis, urine and stool diagnostics, as well as imaging, infection control, and cancer diagnostics. The company has several divisions that focus on different aspects of veterinary diagnostics. IDEXX Diagnostics is the largest business segment, offering veterinary lab services, diagnostic tests, and software solutions. IDEXX Water is a company specializing in the analysis of water samples and monitoring of environmental conditions. IDEXX Livestock, the newest division of IDEXX, provides veterinary solutions for agricultural and livestock operations. Key products of IDEXX include tests for parasites, infections, diabetes, and kidney function. The company has also developed some innovative products, such as SNAP tests, which provide fast and accurate results and can perform tests for various pathogens simultaneously. IDEXX is also a company committed to sustainability. The IDEXX Foundation was established in 2013 and has since donated over $32 million to local and global projects that aim to protect animals and the environment. Overall, IDEXX Laboratories Inc is a company specialized in veterinary diagnostic and IT solutions to support veterinarians in treating animals. The wide range of solutions and products, as well as the commitment to sustainability, make the company an important player in the market for veterinary diagnostics. IDEXX Laboratories ist eines der beliebtesten Unternehmen auf Eulerpool.com.

IDEXX Laboratories revenue by segment

  • 88 % Companion Animal Group

  • 6 % Water

  • 5 % Livestock, Poultry & Dairy

  • 1 % Other

ROE Details

Decoding IDEXX Laboratories's Return on Equity (ROE)

IDEXX Laboratories's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing IDEXX Laboratories's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

IDEXX Laboratories's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in IDEXX Laboratories’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about IDEXX Laboratories stock

What is the ROE (Return on Equity) of IDEXX Laboratories this year?

The ROE of IDEXX Laboratories this year is 0.56 undefined.

How has the Return on Equity (ROE) of IDEXX Laboratories developed compared to the previous year?

The ROE of IDEXX Laboratories has increased by -2.23% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of IDEXX Laboratories?

A high ROE indicates that IDEXX Laboratories generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of IDEXX Laboratories?

A low ROE can indicate that IDEXX Laboratories is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of IDEXX Laboratories affect the company?

A change in ROE (Return on Equity) of IDEXX Laboratories can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of IDEXX Laboratories?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of IDEXX Laboratories?

Some factors that can influence IDEXX Laboratories's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does IDEXX Laboratories pay?

Over the past 12 months, IDEXX Laboratories paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, IDEXX Laboratories is expected to pay a dividend of 0 USD.

What is the dividend yield of IDEXX Laboratories?

The current dividend yield of IDEXX Laboratories is .

When does IDEXX Laboratories pay dividends?

IDEXX Laboratories pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of IDEXX Laboratories?

IDEXX Laboratories paid dividends every year for the past 0 years.

What is the dividend of IDEXX Laboratories?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is IDEXX Laboratories located?

IDEXX Laboratories is assigned to the 'Health' sector.

Wann musste ich die Aktien von IDEXX Laboratories kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of IDEXX Laboratories from 2/23/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 2/23/2025.

When did IDEXX Laboratories pay the last dividend?

The last dividend was paid out on 2/23/2025.

What was the dividend of IDEXX Laboratories in the year 2024?

In the year 2024, IDEXX Laboratories distributed 0 USD as dividends.

In which currency does IDEXX Laboratories pay out the dividend?

The dividends of IDEXX Laboratories are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The IDEXX Laboratories stock can be added to a savings plan with the following providers: Trade Republic and Consorsbank

Andere Kennzahlen von IDEXX Laboratories

Our stock analysis for IDEXX Laboratories Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of IDEXX Laboratories Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.